v3.26.1
Stockholders' Equity and Stock-based Compensation (Tables)
9 Months Ended
Mar. 31, 2026
Stockholders' Equity and Stock-based Compensation [Abstract]  
Schedule of Compensation Expense Allocated For the three and nine months ended March 31, 2026, the Company recorded stock-based compensation expense allocated as follows (in thousands):

 

 

 

For the
Three Months Ended

 

 

For the
Nine Months Ended

 

 

 

March 31, 2026

 

 

March 31, 2026

 

Selling, general and administrative and research and development expenses

 

$

186

 

 

$

186

 

Total

 

$

186

 

 

$

186

 

Summary of Restricted Stock Units ("RSUs") Activity

A summary of the restricted stock units ("RSUs") activity during the nine months ended March 31, 2026 is presented below:

 

 

 

Number of
RSUs

 

 

Weighted Average Grant Date Price

 

RSUs June 30, 2025

 

 

-

 

 

 

-

 

Granted

 

 

326,312

 

 

$

4.89

 

Vested

 

 

-

 

 

 

-

 

Forfeited

 

 

-

 

 

 

-

 

RSUs undelivered March 31, 2026

 

 

326,312

 

 

$

4.89

 

Summary of the Warrant Activity

A summary of the warrant activity during the nine months ended March 31, 2026 is presented below:

 

 

Number of Warrants

 

Outstanding as of June 30, 2025

 

-

 

Issued

 

30,203,376

 

Exercised

 

(382,095

)

Outstanding as of March 31, 2026

 

29,821,281

 

Schedule of Warrants Outstanding

The following table presents information related to warrants as of March 31, 2026:

 

Exercise Price

 

Outstanding Number of Warrants

 

Weighted Average Remaining Life in Years

 

$

9.38

 

 

9,131,600

 

 

4.7

 

$

12.50

 

 

9,131,600

 

 

4.7

 

$

18.75

 

 

9,131,600

 

 

4.7

 

$

6.25

 

 

2,400,001

 

 

4.3

 

Various (> $47.00)

 

 

26,480

 

Various

 

 

 

 

29,821,281